PHARMING GROUP NV (PHARM.AS)

NL0010391025 - Common Stock

0.774  -0.01 (-0.9%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
198.871M
-6.27%
205.622M
3.39%
245.316M
19.30%
303.37M
23.66%
EBITDA
YoY % growth
43.61M
-48.43%
23.555M
-45.99%
-5.825M
-124.73%
7.725M
232.62%
EBIT
YoY % growth
24M
-68.53%
10.367M
-56.80%
-21.75M
-309.80%
985.195K
104.53%
Operating Margin
12.07%5.04%-8.87%0.32%
EPS
YoY % growth
0.02
-55.95%
N/A
101.60%
-0.02
-132.92%
0.00
116.09%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth
0.01
Revenue
Q2Q % growth
76.668M
39.66%
EBITDA
Q2Q % growth
14.626M
241.55%
EBIT
Q2Q % growth
-2.235M
85.85%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth
-0.02
-11.76%
0.01-0.03-363.52%
Q4 2023
Q2Q % growth
0.00
80.00%
0.01-0.01-138.83%
Q3 2023
Q2Q % growth
0.01
-61.54%
-0.030.03118.67%
Q2 2023
Q2Q % growth
0.00
-100.00%
-0.010.01100.00%
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth
55.586M
30.66%
70.478M-14.892M-21.13%
Q4 2023
Q2Q % growth
81.217M
48.69%
74.933M6.284M8.39%
Q3 2023
Q2Q % growth
66.661M
22.90%
63.18M3.481M5.51%
Q2 2023
Q2Q % growth
54.897M
9.47%
54.363M534K0.98%
Q1 2023
Q2Q % growth
Q4 2022
Q2Q % growth
Q3 2022
Q2Q % growth
Q2 2022
Q2Q % growth
Q1 2022
Q2Q % growth
Q4 2021
Q2Q % growth
Q3 2021
Q2Q % growth
Q2 2021
Q2Q % growth
Q1 2021
Q2Q % growth
Q4 2020
Q2Q % growth
Q3 2020
Q2Q % growth
Q2 2020
Q2Q % growth
Q1 2020
Q2Q % growth
Q4 2019
Q2Q % growth
Q3 2019
Q2Q % growth
Q2 2019
Q2Q % growth
Q1 2019
Q2Q % growth
Q4 2018
Q2Q % growth
Q3 2018
Q2Q % growth
Q2 2018
Q2Q % growth
Q1 2018
Q2Q % growth
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 0% 0% -69.7%
Revenue0% 0% 0% 3.08%